Russia's Lukoil plans to sell Bulgarian refinery to Qatari-British consortium, FT reports-March 2024-www.financetom.com

Russia's Lukoil plans to sell Bulgarian refinery to Qatari-British consortium, FT reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Russia's Lukoil plans to sell Bulgarian refinery to Qatari-British consortium, FT reports

Nov 5, 2024 10:33 AM

Nov 5 (Reuters) - Russian state energy group Lukoil is

planning to sell its refinery in Bulgaria to a Qatari-British

consortium by the end of the year, the Financial Times reported

on Tuesday.

(Reporting by Angela Christy in Bengaluru)

Previous page： Uniqure Insider Sold Shares Worth $1,177,517, According to a Recent SEC Filing Next page： Akamai Q3 Adjusted Earnings, Revenue Rise; Updates Guidance

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Uniqure Insider Sold Shares Worth $1,177,517, According to a Recent SEC Filing

Nov 6, 2025

05:08 PM EST, 11/06/2025 (MT Newswires) -- Jack Kaye, Director, on November 04, 2025, sold 38,810 shares in Uniqure ( QURE ) for $1,177,517. Following the Form 4 filing with the SEC, Kaye has control over a total of 20,439 ordinary shares of the company, with 20,439 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1590560/000090445425000560/xslF345X05/edgar.xml ...

Akamai Q3 Adjusted Earnings, Revenue Rise; Updates Guidance

Nov 6, 2025

05:08 PM EST, 11/06/2025 (MT Newswires) -- Akamai Technologies ( AKAM ) reported Q3 adjusted earnings late Thursday of $1.86 per diluted share, up from $1.59 a year ago. Analysts polled by FactSet expected $1.64. Revenue for the three months ended Sept. 30 was $1.055 billion, up from $1.00 billion a year earlier. Analysts surveyed by FactSet expected $1.04 billion....

Medical devices firm Sensus Healthcare Q3 revenue beats estimates on higher FDA treatment volumes

Nov 6, 2025

Overview * Sensus Healthcare Q3 2025 revenue of $6.9 mln beats analyst expectations * Net loss for Q3 2025 was $0.9 mln, reflecting operational challenges * Adjusted EBITDA for Q3 2025 missed analyst estimates Outlook * Company sees strong interest internationally following MDSAP certification * CMS coding expected to strengthen SRT adoption and reimbursement certainty Result Drivers * INCREASED TREATMENT...

Joint Q3 revenue slightly beats expectations

Nov 6, 2025

Overview * Joint Q3 revenue grows 6% to $13.4 mln, slightly beating analyst expectations * Net income improves to $855,000 from a loss of $3.2 mln in Q3 2024 * Board authorizes additional $12 mln for share repurchases Outlook * Company updates 2025 system-wide sales guidance to $530 mln-$534 mln from $530 mln-$550 mln * Comp sales now expected to...